Harvard Bioscience (HBIO) Earnings Date & Reports

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

HBIO is expected to report earnings to fall 116.67% to 0 cents per share on May 13

Harvard Bioscience HBIO Stock Earnings Reports

Q1'25

Est.

$-0.01

Q4'24

Beat

by $0.01

Q3'24

Missed

by $0.04

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.03

The last earnings report on March 12 showed earnings per share of 5 cents, beating the estimate of 5 cents. With 355.88K shares outstanding, the current market capitalization sits at 184.01M.

View a ticker or compare two or three

Compare

HBIO